The intersection of personalized cardiology and precision medicine offers a new frontier in the treatment of heart conditions. Through the use of genomic data, personalized cardiology allows for customized treatment plans that focus on an individual’s genetic predispositions and lifestyle factors. This level of individualized care ensures that patients receive therapies that are specifically suited to their needs, reducing the trial-and-error approach often seen in traditional medicine. By leveraging precision medicine, cardiologists can now predict how patients will respond to specific treatments, offering a more effective, proactive approach to managing cardiovascular diseases and improving patient outcomes.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with Major Adverse Cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical School, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico
Title : Metabolic and echocardiographic predictors of ventricular extrasystoles burden in non-ischemic patients
Ahmed Ahmed Mohamed Hassan, Al-Azhar Medical School, Egypt